Vascular function, systemic inflammation, and coagulation activation 18 months after COVID-19 infection: an observational cohort study

LH Willems, LMC Jacobs, LA Groh, H Ten Cate… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Among its effect on virtually all other organs, COVID-19 affects the
cardiovascular system, potentially jeopardizing the cardiovascular health of millions …

[HTML][HTML] Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19

LH Willems, M Nagy, H Ten Cate, HMH Spronk… - Thrombosis research, 2022 - Elsevier
Introduction Endothelial damage and thrombosis caused by COVID-19 may imperil
cardiovascular health. More than a year since the WHO declared COVID-19 pandemic …

Biomarkers of coagulation, endothelial, platelet function, and fibrinolysis in patients with COVID-19: a prospective study

MJ SB, B Chacko, S Selvarajan, JV Peter, T Geevar… - Scientific Reports, 2024 - nature.com
Prospective and sequential evaluation of homeostatic changes leading to thrombosis across
COVID 19 disease severity spectrum are limited. In this prospective observational study …

Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6-and 12-months SARS-CoV-2 infection

P Poyatos, N Luque, G Sabater, S Eizaguirre, M Bonnin… - Infection, 2024 - Springer
Introduction SARS-CoV-2 infection causes severe endothelial damage, an essential step for
cardiovascular complications. Endothelial-colony forming cells (ECFCs) act as a biomarker …

Evaluation of endothelial dysfunction and inflammatory vasculopathy after SARS-CoV-2 infection—a cross-sectional study

P Jud, P Gressenberger, V Muster, A Avian… - Frontiers in …, 2021 - frontiersin.org
Background: Rising data suggest that COVID-19 affects vascular endothelium while the
underlying mechanisms promoting COVID-19-associated endothelial dysfunction and …

Persisting endothelial cell activation and hypercoagulability after COVID-19 recovery—the prospective observational ROADMAP-Post COVID-19 study

GT Gerotziafas, P Van Dreden, TN Sergentanis… - Hemato, 2022 - mdpi.com
Background. Hypercoagulable state and endothelial cell activation are common alterations
in patients with COVID-19. Nevertheless, the hypothesis of persistent hypercoagulability and …

Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2 …

LMC Jacobs, MSJN Wintjens, M Nagy… - Frontiers in …, 2023 - frontiersin.org
Introduction Comprehensive studies investigating sustained hypercoagulability, endothelial
function, and/or inflammation in relation to post-COVID-19 (PCC) symptoms with a …

Circulating markers of angiogenesis and endotheliopathy in COVID-19

AB Pine, ML Meizlish, G Goshua… - Pulmonary …, 2020 - journals.sagepub.com
Increase in thrombotic and microvascular complications is emerging to be a key feature of
patients with critical illness associated with COVID-19 infection. While endotheliopathy is …

Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection

A Boccatonda, E Campello, C Simion… - Expert Review of …, 2023 - Taylor & Francis
Introduction both symptomatic and asymptomatic SARS-CoV-2 infections–coined
Coronavirus disease 2019 (COVID-19)–have been linked to a higher risk of cardiovascular …

Carotid intima-media thickness and flow-mediated dilation do not predict acute in-hospital outcomes in patients hospitalized with COVID-19

M Cristina-Oliveira, K Meireles, S Gil… - American Journal …, 2022 - journals.physiology.org
Studies have suggested a potential role of endothelial dysfunction and atherosclerosis in the
pathophysiology of COVID-19. Herein, we tested whether brachial flow-mediated dilation …